Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News
Renexxion and Dr. Falk Pharma Begin U.S. Patient Dosing in Global Phase 2b Study for Promising Gastroparesis Treatment

Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high u...

August 14, 2024 | Wednesday | News
Persist AI and Nivagen Announce Strategic Collaboration to Transform Long-Acting Injectable Drug Manufacturing

Persist AI and Nivagen have announced a collaboration to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, ...

August 13, 2024 | Tuesday | News
Ascendis Pharma’s YORVIPATH® Offers Continuous PTH Therapy, Meeting Critical Needs of Over 70,000 U.S. Hypoparathyroidism Patients

Hypoparathyroidism is a rare endocrine disease with multi-organ impacts affecting an estimated 70,000 to 90,000 people in the United States Ascendi...

August 12, 2024 | Monday | News
MSD Discontinues Phase 3 KeyVibe-008 Trial for Extensive-Stage Small Cell Lung Cancer

Merck (NYSE: MRK), known as MSD outside of the United States and Canada,  announced the discontinuation of the Phase 3 KeyVibe-008 trial based on th...

August 09, 2024 | Friday | News
Daiichi Sankyo and MSD Expand Collaboration to Co-Develop and Co-Commercialize DLL3 T-Cell Engager MK-6070

Agreement builds on and complements Daiichi Sankyo and Merck’s shared commitment to develop novel medicines for patients with cancer Daiichi Sanky...

August 07, 2024 | Wednesday | News
Baylor Genetics and Baylor College of Medicine Launch New Lab to Advance Clinical Diagnostics

Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, and the Department of Molecular and Human Genetics a...

August 06, 2024 | Tuesday | News
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovia...

August 05, 2024 | Monday | News
MilliporeSigma Acquires Mirus Bio for $600 Million, Enhancing Viral Vector Manufacturing Capabilities

Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...

August 02, 2024 | Friday | News
CooperCompanies Acquires obp Surgical for $100 Million, Expanding Surgical Device Portfolio

CooperCompanies announced that CooperSurgical has acquired obp Surgical, a U.S.-based medical device company with a suite of single-use cordless surgical...

August 02, 2024 | Friday | News
AbbaDox and Merge Healthcare Solutions Announce Strategic Partnership for Enhanced Radiology Workflow Solutions

AbbaDox, a leading provider of cloud-based healthcare solutions, is pleased to announce a strategic relationship with Merge Healthcare Solutions to deliv...

July 26, 2024 | Friday | News
Agilent Acquires BIOVECTRA: Transformative Deal Enhances Capabilities with Advanced Biologics, Gene Editing, and High-Potency Therapeutics

Agilent announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, f...

July 23, 2024 | Tuesday | News
Johnson & Johnson Seeks FDA Approval for SPRAVATO® Nasal Spray as Monotherapy for Treatment-Resistant Depression

Johnson & Johnson  announced  the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) s...

July 23, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close